1,3-diphenylisobenzofuran has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, X; Gao, J; Lin, H; Lin, Y; Luo, X; Yang, Z | 1 |
| Chen, X; Guo, Z; Li, Y; Lin, L; Liu, F; Tian, H; Wang, D; Wang, Y; Zhang, Z | 1 |
2 other study(ies) available for 1,3-diphenylisobenzofuran and Neoplasms
| Article | Year |
|---|---|
A camptothecin prodrug induces mitochondria-mediated apoptosis in cancer cells with cascade activations.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzofurans; Camptothecin; Cell Line, Tumor; Drug Therapy, Combination; Humans; Mitochondria; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prodrugs; Reactive Oxygen Species | 2021 |
Porphyrin-based covalent organic framework nanoparticles for photoacoustic imaging-guided photodynamic and photothermal combination cancer therapy.
Topics: Animals; Benzofurans; Cell Line, Tumor; Combined Modality Therapy; Female; Hemolysis; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Organic Chemicals; Photoacoustic Techniques; Phototherapy; Porphyrins; Rabbits; Reactive Oxygen Species | 2019 |